Curriculum Vitae dr. Stefaan Johan Noël Vandecasteele

  • private address :Lodistraat 123

8020 Hertsberge

Belgium

Tel +3250680706

Tel +32477333138

  • professional address:Dr. Vandecasteele Stefaan

Dept. Nephrology and Infectious Diseases

AZ Sint-Jan Brugge-Oostende AV

Ruddershove 10

B-8000 Brugge

Tel +3250452204

Fax +3250452299

E-mail :

  • Date and place of birth: 4th of May 1972, Kortrijk, Belgium
  • Nationality: Belgian
  • Civil status: Divorced
  • Children:Daniëlle, ° 11th January 1998

Elizabeth, ° 27th June 1999

Nathan, °16th June 2002

Mathieu, ° 8 March 2004

  • Languages: First language: Dutch; Other languages : English, French and some notions of Spanish

STUDIES

  • Education:

-Undergraduate, Spes Nostra College, Kuurne, Belgium,

Mathematics and Sciences: Great Honour

-1990-1993: Catholic University of Leuven, Belgium

Candidate in Medicine: Greatest Honour with summa cum laude

-1993-1997: Catholic University of Leuven, Belgium

Medical Doctor: Greatest Honour

-Training in Gynaecology and Paediatrics from November 1995 till February 1996 In Guayacil, Ecuador

-7th May 2003: Doctor in Medical Science (PhD), Catholic University of Leuven, Belgium: “A study on the mechanisms involved in the pathogenesis of foreign body infections caused by coagulase-negative staphylococcae”

-30th June 2016: International Society of Travel Medicine, certificate of excellence

  • Postgradual Education:

-Research Assistant of the Fund for Scientific Research – Flanders (Belgium)(F.W.O.-Vlaanderen) in the Infectious Diseases Research Group at the University of Leuven (Prof. Dr. Van Eldere Johan and Prof. Dr. Peetermans Willy): 1-10-1999 to 30-09-2003.

-November 2000: Research Grant from the Belgium Society of Clinical Microbiology and Infectious Diseases

-January 2002: Travel grant for the 12th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 24-27 April 2002, Milan

-June 2002: Mc Cracken Infectious Disease travel grant for the 42nd ICAAC, 27-29 September 2002, San Diego

-December 2002: Poster grant BVIKM symposium

-24th March 2004: Yourrasowsky award for microbiology and Infectious Diseases

-2003-2004: Training ‘Antibiotica beleid commissies’

-31st July 2004: Specialist in General Internal Medicine and Infectious Diseases, Catholic University of Leuven

-30th November 2005: Specialist in Nephrology; Catholic University of Leuven and Sint-Jan Hospital, Brugge

WORK EXPERIENCE

  • Current position:
  • Since 1th December 2005: staff member of nephrology AZ Sint-Jan Brugge Oostende AV, responsible of Travel Clinic and AIDS reference centre
  • Consultancy in Ghent University (General Internal Medicine); AZ Groeninge Kortrijk and the Flamish Prison

MEMBERSHIP SCIENTIFIC SOCIETIES

-Belgische Vereniging voor Infectiologie en Klinische Microbiologie/Société Belge

d’Infectiologie et de Microbiologie Clinique

-Belgische Nederlandse Vereniging voor Nefrologie

-Belgium-Luxemburg antibiotic guide working group (former Sanford)

-Lid van de BAPCOP (Belgium antibiotic Policy Coordination Committee)

publications

  • Publication in local press:
  1. Vandecasteele S.J, Cassiman D, Pinxten W, Simoens S, Aertgeerts B, Deville L,

De groeiende gaten in ons gezondheidssysteem. De Standaard, 1 februari 2014, Opinie pg 42-43.

  1. Vandecasteele S.J., Cassiman D, Pinxten W, Simones S, Aertgeerts B, Deville L, Firre E, Moerman F. Une vision pour l’avenir après 50 ans de soins de santé en Belgique. Le Soir, 11 février 2014, Forum pg 22-23.
  • Other publications:
  1. Vandecasteele SJ, Van Wijngaerden E, Van Eldere J, Peetermans W: New insights in the pathogenesis of foreign-body infections. Acta Clin Belg. 2000: 55(3):148-153.
  2. Vandecasteele SJ, Peetermans WE, Merckx R, Van Eldere J: Quantification of the expression of Staphylococcus epidermidis housekeeping genes with taqman quantitative PCR during in vitro growth an under different conditions. J Bacteriol. 2001: 183(24):7094-7101.
  3. Vandecasteele SJ, Knockaert D, Verhaegen J, Van Eldere J, Peetermans WE: The antibiotic and anti-inflammatory treatment of bacterial meningitis in adults: do we have to change our strategies in an era of increasing antibiotic resistance? Acta Clin Belg. 2001:56(4):225-233.
  4. Vandecasteele SJ, Verhaegen J, Colaert J, Van Caster A, Devlieger H: Failure of cefotaxime and meropenem to eradicate meningitis caused by an intermediately susceptible Streptococcus pneumoniae strain. Eur J Clin Microbiol Infect Dis. 2001: 20:751-752.
  5. Vandecasteele SJ, Peetermans WE, Bobbaers H: Behandeling van “Community-acquired” pneumonie: monotherapie of combinatie van antibiotica ? Tijdschrift voor Geneeskunde. 2001:57(20):1438-1444.
  6. Rijnders BA., Verwaest C, Peetermans WE, Wilmer A, Vandecasteele S, Van Eldere J, Van Wijngaerden E: Difference in time to positivity of hub-blood versus nonhub-blood cultures is not useful for the diagnosis of catheter-related bloodstream infection in critically ill patients. Crit Care Med. 2001:29(7):1399-1403.
  7. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Peetermans WE: Uncertainties and Future Research Topics in the Management of Suspected Catheter-Related Infection. Clin Infect Dis. 2001: 33(11):1946.
  8. Vandecasteele SJ, Peetermans WE, Merckx R., Van Ranst M. and Van Eldere J: Use of gDNA as internal standard for gene expressioin in staphylococci in vitro and in vivo. Biochem Biophys Res Commun. 2002: 291:528-534.
  9. Vandecasteele SJ, Verhaegen J and Peetermans WE: Cause and timing of death following meningitis in adults. Clin Infect Dis. 2002;34:878-9.
  10. Vandecasteele SJ, Frans J and Van Ranst M: Contamination management of broad-range ribosomal DNA PCR: where is the evidence? Journal of Clin Microbiol. 2002:40: 3885-3886.
  11. Vandecasteele SJ, Boelaert JR, Verrelst P., Graulus E, Gordts BZ: Diagnosis and treatment of Aspergillus flavus sternal wound infections after cardiac surgery. Clin Inf Dis. 2002: 35: 887-890.
  12. Vandecasteele SJ, Peetermans WE, Merckx R, Rijnders BJA and Van Eldere J: Reliability of the ica,aap and atlE Genes in the Discrimination between Invasive, Colonizing and Contaminant Staphylococcus epidermidis Isolates in the Diagnosis of Catheter-related Infections. Clin Microbiol Infect. 2003: 9:114-9.
  13. Verhaegen J, Vandecasteele SJ, Vandeven J, Verbiest N, Lagrou K, Peetermans WE: Antibiotic susceptibility and serotype distribution of 240 Streptococcus pneumoniae causing meningitis in Belgium 1997-2000. Acta Clin Belg. 2003. 58:19-26.
  14. Vandecasteele SJ, Peetermans WE, Merckx R, Van Eldere J Expression of biofilm-associated genes in Staphylococcus epidermidis during in vitro and in vivo foreign body infections. Journal of Infectious Diseases. 2003. 188:730-737.
  15. Rijnders BJE, Vandecasteele SJ, Van Wijngaerden E, De Munter P, Peetermans WE: Use of IDSA guidelines for catheter infection. Clinical Infectious Diseases. 2003.37,980-983.
  16. Vandecasteele SJ, Van Eldere J, Merckx R, Peetermans WE: The effect of systemic antibiotics on the microbiological diagnosis of experimental foreign body infections caused by Staphylococcus epidermidis.Diagnost Microbiol Infect Dis. 2004. 48;89-95.
  17. Vandecasteele SJ, Peetermans WE, Carbonez An, Van Eldere J: The metabolic activity of Staphylococcus epidermidis is high during initial and low during late experimental foreign-body infection. J Bacteriol. 2004. 186, 2236-2239.
  18. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E: Invasive aspergillosis in critically ill patients without malignancy. Am J Resp Crit Care Med 2004. 170, 621-625.
  19. Vandecasteele SJ, Van Wijngaerden E, Peetermans WE. Two cases of severe phototoxic reactions related to long-term outpatient treatment with voriconazole. Eur J Clin Microbiol Infect Dis. 2004. 23:656-7.
  20. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother. 2005. 55:90-4.
  21. Vandecasteele SJ, Maes B, Claes K, Sciot R, Vanrenterghem Y. High anti-double-stranded DNA antibodies and progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Nephrol Dial Transplant. 2005 Jun;20:1246-7.
  22. Kuypers DR, Claes K, Evenepoel P, Maes B, Vandecasteele S, Vanrenterghem Y, Van Damme B, Desmet K. Drug Interaction Between Itraconazole and Sirolimus in a Primary Renal Allograft Recipient. Transplantation. 2005. 79:737.
  23. Van den Bergh B, Selleslag D, Boelaert JR, Matthys EG, Schurgers M, Vandecasteele S, De Vriese A. Management of therapy-resistant systemic lupus erythematosus with rituximab: report of a case and review of the literature. Acta Clin Belg. 2005. 60:102-5.
  24. De Vriese AS, Coster RV, Smet J, Seneca S, Lovering A, Van Haute LL, Vanopdenbosch LJ, Martin JJ, Groote CC, Vandecasteele S, Boelaert JR. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis. 2006 42(8):1111-7.
  25. Orlent H, Selleslag D, Vandecasteele S, Jalal PK, Bank S, Hines J. Clinical challenges and images in GI. Fasciola hepatica infection and Von Hippel-Lindau disease type 1 with pancreatic and renal involvement. Gastroenterology. 2007 132, 467-8.
  26. Boelaert JR, Vandecasteele SJ, Appelberg R, Gordeuk VR. The effect of the host's iron status on tuberculosis. J Infect Dis. 2007 Jun 15;195: 1745-53.
  27. De Geeter F, Vandecasteele SJ. Fluorodeoxyglucose PET in relapsing polychondritis. N Engl J Med. 2008 31;358: 536-7.
  28. Pintens V, Massonet C, Merckx R, Vandecasteele S, Peetermans WE, Knobloch JK, Van Eldere J. The role of sigmaB in persistence of Staphylococcus epidermidis foreign body infection. Microbiology. 2008 154: 2827-36.
  29. Vandecasteele SJ, Boelaert JR, De Vriese AS. Staphylococcus aureus infections in hemodialysis: what a nephrologist should know. Clin J Am Soc Nephrol. 2009 4: 1388-400.
  30. Mylle M, Goubau J, Bourgeois M, Vandecasteele SJ. Necrotizing fasciitis due to Streptococcus pneumoniae in a healthy 68-year old man: case report and review of the literature. Acta Clin Belg. 2009 64: 452-4.
  31. Vandewiele B, Vandecasteele SJ, Vanwalleghem L, De Vriese AS. Diffuse alveolar hemorrhage induced by everolimus. Chest. 2010 Feb;137:456-9.
  32. Vandecasteele SJ, De Vriese AS. Recent changes in vancomycin use in renal failure. Kidney Int, 2010, 77(9):760-4.
  33. Vandecasteele S.J, De Paepe P, De Vriese AS. Successful treatment of renal AA amyloidosis in Familial Mediterranean Fever with pegylated alfa-2a interferon. Clin Nephrol, 2011, 75, S1, 1-3.
  34. Vandecasteele S.J., De Vriese AS. Vancomycin dosing in patients on intermittent haemodialysis. Seminars in Dialysis. 2011. 24, 50-55.
  35. Helsen G., Vandecasteele S.J., Vanopdenbosch L.J. Toxocariasis presenting as encephalomyelitis. Case Report Med. 2011. 503913. Epub 2011 May 5
  36. Vandecasteele S.J., De Bacquer D., De Vriese A.S. Implementation of a dose calculator to achieve trough levels of 15 to 20 µg/ml in persons undergoing hemodialysis: a before-after study. Clin Infect Dis, 2011, 53, 124-9.
  37. De Vriese A.S., Vandecasteele S.J., Van den Bergh B., De Geeter F.W. Should we screen for coronary artery disease in asymptomatic chronic hemodialysis patients ? Kidney Int. 2012. 81, 143-151..
  38. Vandecasteele S.J., De Vriese A.S., Vanhooren G.T.. Reversion of cerebral artery stenoses due to tuberculomas with TNF-alfa antibodies. Clin Neurol Neurosurg. 2012.114(7):1016-8.
  39. Stockman A., Vandecasteele S.J., Maes A., D’Heygere F. Een jonge vrouw met chronische vermoeidheid. Belgisch Tijdschrift voor geneeskunde. 2012. 68, 352-355.
  40. Clerinx J., Vlieghe E., Asselman V., Vandecasteele S., Maes M, Lejon V. Human African trypanosomiasis in a Belgian traveller returning from the Masai Mara area, Kenya, February 2012. Eurosurveillance. 2012. vol 17, issue 10.
  41. Vandecasteele S.J., De Vriese A.S., Tacconelli E. The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties. J Antimicrob Chemother. 2013 Apr;68(4):743-8.
  42. Caluwé R, Vandecasteele S, Van Vlem B, Vermeer C, De Vriese AS. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. Nephrol Dial Transplant. 2013 Nov 26. [Epub ahead of print]
  43. Vandecasteele S.J., De Vriese AS. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med. 2013 Dec 19;369(25):2458-9.
  44. Miranda Bastos AC, Vandecasteele SJ, Tulkens PM, Spinewine A, Van Bambeke F. Development and validation of a high performance liquid chromatography assay for the determination of temocillin in serum of haemodialysis patients. J Pharm Biomed Anal. 2014 Mar 5;90:192-7.
  45. De Vriese AS, Vandecasteele SJ. Vancomycin: the tale of the vanquisher and the pyrrhic victory. Perit Dial Int. 2014 Mar;34(2):154-61.
  46. Vandecasteele S.J., Kurella Tamura M. A patient-centered vision of care for ESRD: dialysis as bridging treatment or as final destination. JASN. 20148:1647-51.
  47. De Ceulaer J, Tacconelli E, Vandecasteele SJ.Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link? Eur J Clin Microbiol Infect Dis. 2014, 33(11): 1873-80.
  48. Van Der Meersch H, De Bacquer D, Vandecasteele SJ, Van den Bergh B, Vermeiren P, De Letter J, De Vriese AS. Hemodialysis Catheter Design and Catheter Performance: A Randomized Controlled Trial. Am J Kidney Dis. 2014, 64(6): 902-908.
  49. Mori M, Van Esbroeck M, Depoorter S, Decaluwe W, Vandecasteele SJ, Fretin D, Reynders M. Outbreak of leptospirosis during a scout in the Luxembourg Belgian province, Belgium, Summer 2012. Epidemiology and infection, 2015, 143(8), 1761-6.
  50. De Vriese AS, Caluwé R, Bailleul E, De Bacquer D, Borrey D, Van Vlem B, Vandecasteele SJ, Emmerechts J. Dose-Finding Study of Rivaroxaban in Hemodialysis Patients. Am J Kidney Dis. 2015, 66(1):91-98.
  51. Vandecasteele SJ, Ombelet S, Blumental S, Peetermans WE. The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. Clin Kidney J. 2015, 8(3):318-324.
  52. Snauwaert C, Vandecasteele SJ, Laukens P. A Painful Perianal Lesion. Gastroenterology. 2015, Jul 28. Eprint ahead of publilcation.
  53. Peeters I, Casselman J, Vandecasteele SJ, Janssen A, Regaert B, Vantomme N, Vanopdenboshc L. Multiple nocardial abscesses of the brainstem and spinal cord: diagnosis after an open biopsy through a cervical partial central corporectomy. J Neurosurgery, 2015, Jun 19:1-4.
  54. Vandecasteele SJ, Miranda Bastos AC, Capron A, Spinewine A, Tulkens PM, Van Bambeke F. Thrice-weekly temocillin administered after each dialysis session is appropriate for the treatment of serious Gram-negative infections in haemodialysis patients. Int J Antimicrob Agents. 2015 Dec;46(6):660-5
  55. Vandecasteele SJ, De Ceulaer J, Wittouck E. Tigecycline Induced Hyperpigmentation of the Skin. Open Forum Infect Dis. 2016 Feb 17;3(1).
  56. De Keukeleire S, Geldof J, De Clerck F, Vandecasteele S, Reynders M, Orlent M.Prolonged course of hepatic granulomatous disease due to Bartonella henselae infection.Acta Gastroenterol Belg. 2016 Sep-Dec;79(4):497-499.
  • Abstracts (international)

Oral presentations

  1. Vandecasteele SJ, Peetermans WE, Merckx R., Van Eldere J. Taqman real-time quantitative PCR is a powerful tool to study gene expression in vitro in Staphylococci. Oral presentation O301. 11th European Congress of Clinical Microbiology and Infectious diseases, 1-4 April 2001. Istanbul, Turkey.
  2. Vandecasteele SJ, Peetermans WE, Merckx R., Van Eldere J. Expression of housekeeping genes during in vitro exponential and early stationary growth of staphylococci. Oral presentation O302. 11th European Congress of Clinical Microbiology and Infectious diseases, 1-4 April 2001. Istanbul, Turkey.
  3. Vandecasteele SJ, Peetermans WE, Merckx R., Rijnders BJA, Van Eldere J. Presence of the ica and aap gene in clinical Staphylococcus epidermidis isolates: diagnostic value and implications for pathogenesis of S. epidermidis foreign body infections. Oral presentation O323. 11th European Congress of Clinical Microbiology and Infectious diseases, 1-4 April 2001. Istanbul, Turkey.
  4. Vandecasteele SJ, Peetermans WE, Merckx R., Van Eldere J. In vivo foreign body infection induces an exponential decrease of protein synthesis in Staphylococcus epidermidis. Oral presentation O142. 12th ECCMID, 24-27 April 2002. Milan, Italy.
  5. Vandecasteele SJ, Van Eldere J, Merckx R., Peetermans W. Optimal timing of prophylactic antibiotics in surgery corresponds with a peak in penicillin-binding protein expression in infecting bacteria. Oral Presentation. 13th ECCMID, 10-13 May 2003.Glasgow, UK.
  6. Vandecasteele SJ, Peetermans W., Merckx R., Van Eldere J. The autolysin atlE is possibly involved in the maintenance of in vivo foreign body infections in Staphylococcus epidermidis. Oral Presentation. 13th ECCMID, 10-13 May 2003. Glasgow, UK.
  7. Rijnders BJA, Vandecasteele SJ, Van Wijngaerden E, De Munter P, Peetermans WE. Automatic and Standardized Treatment Advice to Improve Compliance with IDSA Guidelines for Catheter Infection: an Interrupted Time Series Study. Oral Presentation K-2044. 43th ICAAC, 13-18 September, 2003, Chicago, USA.

Poster presentation

  1. Vandecasteele SJ, Boelaert JR, Verrels P, Godts BZ. Aspergillus flavus sternal wound infections after CABG. 4th international symposium on the management of serious fungal disease: detection, protection and eradication. Poster Presentation. 6-8 april 2000. Cannes, France.
  2. Vandecasteele SJ, Peetermans WE, Merckx R., Van Eldere J. Early foreign body colonisation induces a metabolic phase variation in Staphylococcus epidermidis. Poster presentation 957. 41th ICAAC, 16-19 December 2001. Chicago, USA.
  3. Verhaegen J, Vandeven J, Flamaing J, Lagrou K, Vandecasteele SJ, Van Eldere J, Peetermans WE: Antibiotic susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Belgium, 1997-2000. Poster presentation C2-2111. 41th ICAAC, 16-19 December 2001. Chicago, USA.
  4. Vandecasteele SJ, Van Eldere J, Merckx R., Peetermans WE. Taqman quantitative PCR as a promising tool for the diagnosis of staphylococcal catheter infections. Poster presentation; P1522 12th ECCMID, 24-27 April 2002, Milan, Italy.
  5. Vandecasteele SJ, Van Eldere J, Merckx R., Peetermans WE:Early but not late in vivo foreign body associated growth provokes a transient peak in icaC gene expression in Staphylococcus epidermidis. Poster Presentation B-268, 42nd ICAAC, 27-29 September 2002. San Diego, USA.
  6. Vandecasteele SJ, Van Eldere J, Merckx R., Peetermans WE:Antibiotics induce a decrease in bacterial count and an increase in false-negative catheters when comparing quantitative culture with quantitative PCR for the diagnosis of catheter infections.Poster Presentation D-2012, 42nd ICAAC, 27-29 September 2002, San Diego, USA.
  7. Vandecasteele SJ, Rijnders B, Demunter P, Van Wijngaerden E. A case of fatal lactic acidosis triggered by amphotericin B in an AIDS-patient with visceral leishmaniasis. Poster Presentation. 13th ECCMID, 10-13 May 2003, Glasgow, UK.
  8. Vandecasteele SJ, Peetermans WE, Bertrand I, Van Eldere J: SigB is probably involved in the persistence phase of Staphylococcus epidermidis in in vivo foreign body infections. Poster Presentation. 43th ICAAC, 13-18 September, 2003, Chicago, USA.
  9. Vandecasteele SJ, Van Wijngaerden E, Peetermans WE: Two cases of severe phototoxic reactions related to long-term outpatient voriconazole treatment.(P1786) Poster Presentation. 14th ECCMID, 1-4 May, 2004, Praha, Czech Republic.
  10. W. Meersseman, S.J. Vandecasteele, E. Van Wijngaerden, J. Maertens, A. Wilmer, W.E. Peetermans. Invasive aspergillosis: an emerging pathogen with a huge mortality in non-haemato-oncological patients. (P1000). Poster Presentation. 14th ECCMID, 1-4 May, 2004, Praha, Czech Republic.
  11. Pintens V, Vandecasteele S, Merckx R, Van Eldere J: Role of virulence regulator genes in Staphylococcus epidermidis biofilm formation. Poster Presentation. 15th ECCMID, 2-5 May, 2005, Copenhagen, Denmark.
  • Abstracts (national)

Poster presentations

1.Vandecasteele SJ, Van Eldere J, Merckx R., Peetermans WE. Foreign Body Colonisation Induces a Global but Temporary Metabolic Activation in Staphylococcus epidermidis. Poster Presentation. 17th BVIKM fall meeting, 15 December 2001. Antwerp, Belgium.

  1. Vandecasteele SJ, Peetermans WE, Merckx R., Van Eldere J. Expression of housekeeping genes during in vitro exponential and early stationary growth of staphylococci. 17th BVIKM fall meeting, 15 December 2001. Antwerp, Belgium.
  2. Vandecasteele SJ, Peetermans WE, Merckx R., Van Eldere J. Changes in bacterial metabolism during biofilm-associated infections could explain at least part of the biofilm-resistance. Joint meeting SBIMC/BVIKM-VIZ-NVMM. 7-8 November 2002. Antwerp, Belgium.
  3. Vandecasteele SJ, Van Eldere J, Merckx R., Peetermans WE.The effect of antibiotics on quantitative catheter culture for the diagnosis of catheter-related infections. Joint meeting SBIMC/BVIKM-VIZ-NVMM. 7-8 November 2002. Antwerp, Belgium.
  4. Vandecasteele SJ, Peetermans WE, Merckx R., Van Eldere J. Changes in bacterial metabolism during biofilm-associated infections could explain at least part of the biofilm-resistance. BSM Fall meeting, 17 November 2002. Brussels, Belgium.
  5. Vandecasteele SJ, Peetermans WE, Merckx R., Van Eldere J. Early but not late in vivo foreign body associated growth provokes a transient peak in icaC gene expression in Staphylococcus epidermidis. BSM Fall meeting, 17 November 2002. Brussels, Belgium.
  6. Vandecasteele SJ, Van Eldere J, Merckx R., Peetermans WE.Changes in bacterial metabolism during biofilm-associated infections are a potential new target in the treatment of foreign body related infections. BVIG Autumn meting 2002. Ghent, Belgium.

pag. 1